Methods for personalizing blood flow models

US10674986B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10674986-B2
Application numberUS-201615154360-A
CountryUS
Kind codeB2
Filing dateMay 13, 2016
Priority dateMay 13, 2016
Publication dateJun 9, 2020
Grant dateJun 9, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present approach provides a non-invasive methodology for estimation of coronary flow and/or fractional flow reserve. In certain implementations, various approaches for personalizing blood flow models of the coronary vasculature are described. The described personalization approaches involve patient-specific measurements and do not assume or rely on the resting coronary flow being proportional to myocardial mass. Consequently, there are fewer limitations in using these approaches to obtain coronary flow and/or fractional flow reserve estimates non-invasively.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for generating a patient-specific coronary flow model, comprising: acquiring or generating contrast-enhanced images of a coronary vasculature at one or more cardiac phases, wherein the coronary vasculature comprises one or more vessel segments of interest; analyzing the contrast-enhanced images to determine spatial contrast agent concentration distribution in each vessel segment of interest; accessing a generalized coronary model that models a coronary vasculature comprising at least each vessel segment of interest, wherein the generalized coronary model is parameterized by one or more parameters; and tuning the one or more parameters of the generalized coronary model to generate a patient-specific coronary flow model that replicates the spatial contrast agent concentration distribution in each vessel segment of interest as observed in the contrast-enhanced images. 2. The method of claim 1 , wherein acquiring contrast-enhanced images comprises performing a computed tomography angiography scan or an X-ray angiography scan. 3. The method of claim 1 , wherein determining the spatial contrast agent concentration distribution comprises determining an average opacification at one or more points in each vessel segment of interest. 4. The method of claim 1 , wherein analyzing the contrast-enhanced images comprises determining a vessel centerline and cross-sectional area for the vessel segments of interest. 5. The method of claim 1 , wherein the contrast-enhanced images are acquired following administration of a patterned bolus of contrast agent, wherein the patterned bolus comprises one or more contrast intervals interleaved with a respective low or no contrast interval, wherein the contrast intervals are characterized by higher concentrations of the contrast agent than the respective low or no contrast interval. 6. The method of claim 1 , wherein the generalized coronary model comprises a 1D wave propagation model for vessels coupled to lumped parameter models for one or more of the heart, systemic circulation, and coronary microcirculation and wherein the one or more tuned parameters correspond to lumped model parameters for the coronary microcirculation. 7. The method of claim 1 , wherein tuning the one or more parameters comprises minimizing the difference between contrast agent opacification spatial distribution obtained from images and a predicted contrast agent opacification spatial distribution averaged over the scan duration. 8. The method of claim 7 , wherein the predicted contrast opacification spatial distribution is generated by solving a contrast-agent propagation model in conjunction with the generalized coronary model. 9. The method of claim 8 , wherein the contrast-agent propagation model uses a time variation of contrast agent opacification in the ascending aorta as an inlet boundary condition. 10. The method of claim 9 , wherein the time variation of contrast agent opacification is obtained from a scan separate from a diagnostic scan, wherein a first radiation dose utilized in obtaining the scan is lower than a second radiation dose utilized in obtaining the diagnostic scan. 11. The method of claim 1 , wherein the patient-specific coronary flow model is used to compute a pressure distribution and to estimate fractional flow reserve within the one or more vessel segments of interest. 12. The method of claim 1 , wherein the patient-specific coronary flow model is used to estimate fractional flow reserve for one or more lesions in the coronary vasculature. 13. The method of claim 12 , wherein the one or more lesions comprises one or more stenosis or narrowings in the coronary vasculature. 14. A method for generating a patient-specific coronary flow model, comprising: acquiring or generating contrast-enhanced images of a coronary vasculature at one or more cardiac phases, wherein the coronary vasculature comprises one or more vessel segments of interest; analyzing the contrast-enhanced images to determine spatial contrast agent concentration distribution in each vessel segment of interest; accessing a generalized coronary model that models a coronary vasculature comprising at least each vessel segment of interest, wherein the generalized coronary model is parameterized by one or more parameters; and tuning the one or more parameters of the generalized coronary model to generate a patient-specific coronary flow model that replicates the spatial contrast agent concentration distribution in each vessel segment of interest as observed in the contrast-enhanced images; wherein the contrast-enhanced images are acquired following administration of a patterned bolus of contrast agent, wherein the patterned bolus comprises one or more contrast intervals interleaved with a respective low or no contrast interval, wherein the contrast intervals are characterized by higher concentrations of the contrast agent than the respective low or no contrast interval.

Assignees

Inventors

Classifications

  • involving the use of contrast agents · CPC title

  • involving processing of raw data to produce diagnostic data · CPC title

  • for diagnosis of blood vessels, e.g. by angiography · CPC title

  • A61B6/5217Primary

    extracting a diagnostic or physiological parameter from medical diagnostic data · CPC title

  • Arrangements for generating radiation specially adapted for radiation diagnosis · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10674986B2 cover?
The present approach provides a non-invasive methodology for estimation of coronary flow and/or fractional flow reserve. In certain implementations, various approaches for personalizing blood flow models of the coronary vasculature are described. The described personalization approaches involve patient-specific measurements and do not assume or rely on the resting coronary flow being proportion…
Who is the assignee on this patent?
Gen Electric
What technology area does this patent fall under?
Primary CPC classification A61B6/5217. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).